Rich Danker, the chief spokesman for Health Secretary Robert F. Kennedy Jr., resigned on Wednesday in protest against the Trump administration’s decision to permit major tobacco companies to sell flavored e-cigarettes. His resignation came just one day after Food and Drug Administration Commissioner Dr. Marty Makary also stepped down, citing concerns over the same controversial vaping policy.
According to a resignation letter obtained by The New York Times, Danker warned President Donald Trump that approving flavored vaping products could encourage more teenagers and young adults to start vaping. He argued that increased youth vaping could lead to serious health risks, including nicotine addiction, respiratory illnesses, and potential cancer-related complications.
Despite his criticism of the new FDA policy, Danker made it clear that he did not personally blame Trump. In his letter, he praised the president, writing that Trump had “twice restored our prosperity and national security against all odds.” Instead, Danker pointed to unnamed senior officials within the Department of Health and Human Services, excluding Kennedy, as the driving force behind the policy change.
The updated FDA policy, posted on the agency’s website Friday, outlined plans to crack down on illegal e-cigarette products while allowing the sale of flavored vaping products that had already moved through portions of the FDA approval process. Supporters argue the policy creates clearer regulations for the vaping industry, while critics fear it could weaken protections designed to reduce youth nicotine use.
Reports indicate that Dr. Marty Makary attempted to block the approval of flavored e-cigarettes before being overruled. Sources familiar with the matter said President Trump played a direct role in pushing the policy forward.
The resignations highlight growing tensions within the administration over public health policy, tobacco regulation, and the future of flavored e-cigarettes in the United States.


Trump Envoy Meets Sudan Army Chief in Egypt
US Waives $320M Egypt Military Aid Conditions After Iran War Role
US Pressures Allies to Distance From Anti-Disinformation Conference
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
US DOT Ends Airline Privacy Review Without Enforcement
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
CFTC Moves to Define Prediction Markets as Swaps
France to Release 10 Million Barrels of Diesel to Ease Fuel Prices
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Vance Demands Iran Cut Nuclear Enrichment to End War
US-Taiwan Ties Remain Strong as Taipei Urges Timely Arms Deliveries
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
SEC Investor Reform Validates Barry Silbert’s Tokenization Vision
New York Declares Measles Disaster Emergency as Cases Surge
Israel Tightens Pilot Security After Flydubai Incident
Lula Weighs Alckmin as Finance Minister to Boost Fiscal Credibility 



